Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: Russian Bear who wrote (835)	3/24/1998 6:04:00 PM
From: WTDEC	Read Replies (1) \| Respond to of 1826

RB, have been away for the past week and noted with interest MOGN's price action/volume. Do you have any clue as to what is going on? I do have to admit this one has been fun recently. Regards, Walter

To: Russian Bear who wrote (835)	3/24/1998 6:15:00 PM
From: David Cathcart	Read Replies (1) \| Respond to of 1826

Bear, "Might Trade in Double digits." I like that. I told my brother early last week that MOGN was a "powder keg." He got a good laugh out of that but went out and bought another 2,000 shares @ $4.75. Not bad timing. Stu, For more info on the current state of the clinical trials, go to posts #638 and #760. It may take you a while to read them, but there is a lot of information on MOGN is the earlier posts on this thread. Let's ship some Salagen! Let's shrink some tumors! Let's sign on a European partner! David